Protective role of neuropeptideY Y 2 receptors in cell death and microglial response following methamphetamine injury

European Journal of Neuroscience

Volumn 36, Issue 9, 2012, Pages 3173-3183

  Gonçalves, Joana ^a   Ribeiro, Carlos F ^a   Malva, João O ^a,b   Silva, Ana P ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Cell death; Hippocampus; Methamphetamine; Microglia; NeuropeptideY

Indexed keywords

NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; BAX PROTEIN, MOUSE; BCL2 PROTEIN, MOUSE; METHAMPHETAMINE; NEUROPEPTIDE Y RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL PROTECTION; CONTROLLED STUDY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; MICROGLIA; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL LINE; CYTOLOGY; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; HIPPOCAMPUS; METABOLISM; NERVE CELL;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE; HIPPOCAMPUS; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICROGLIA; NEURONS; NEUROPEPTIDE Y; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, NEUROPEPTIDE Y; TRANSCRIPTION, GENETIC;

EID: 84868532102     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2012.08232.x     Document Type: Article

References (79)

1. Aizenman, E., McCord, M.C., Saadi, R.A., Hartnett, K.A. & He, K. (2010) Complex role of zinc in methamphetamine toxicity in vitro. Neuroscience, 171, 31-39.
2. Almeida, R.D., Manadas, B.J., Melo, C.V., Gomes, J.R., Mendes, C.S., Graos, M.M., Carvalho, R.F., Carvalho, A.P. & Duarte, C.B. (2005) Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ., 12, 1329-1343.
3. Álvaro, A.R., Rosmaninho-Salgado, J., Santiago, A.R., Martins, J., Aveleira, C., Santos, P.F., Pereira, T., Gouveia, D., Carvalho, A.L., Grouzmann, E., Ambrosio, A.F. & Cavadas, C. (2007) NPY in rat retina is present in neurons, in endothelial cells and also in microglial and Muller cells. Neurochem. Int., 50, 757-763.
4. Bachmann, R.F., Wang, Y., Yuan, P., Zhou, R., Li, X., Alesci, S., Du, J. & Manji, H.K. (2009) Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage. Int. J. Neuropsychopharmacol., 12, 805-822.
5. Baptista, S., Bento, A.R., Goncalves, J., Bernardino, L., Summavielle, T., Lobo, A., Fontes-Ribeiro, C., Malva, J.O., Agasse, F. & Silva, A.P. (2012) NeuropeptideY promotes neurogenesis and protection against methamphetamine-induced toxicity in mouse dentate gyrus-derived neurosphere cultures. Neuropharmacology, 62, 2413-2423.
6. Bedoui, S., Miyake, S., Lin, Y., Miyamoto, K., Oki, S., Kawamura, N., Beck-Sickinger, A., von Horsten, S. & Yamamura, T. (2003) NeuropeptideY (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo. J. Immunol., 171, 3451-3458.
7. Bedoui, S., von Horsten, S. & Gebhardt, T. (2007) A role for neuropeptideY (NPY) in phagocytosis: implications for innate and adaptive immunity. Peptides, 28, 373-376.
8. Bedoui, S., Kromer, A., Gebhardt, T., Jacobs, R., Raber, K., Dimitrijevic, M., Heine, J. & von Horsten, S. (2008) NeuropeptideY receptor-specifically modulates human neutrophil function. J. Neuroimmunol., 195, 88-95.
9. Berglund, M.M., Hipskind, P.A. & Gehlert, D.R. (2003) Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp. Biol. Med. (Maywood), 228, 217-244.
10. Bernardino, L., Xapelli, S., Silva, A.P., Jakobsen, B., Poulsen, F.R., Oliveira, C.R., Vezzani, A., Malva, J.O. & Zimmer, J. (2005) Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J. Neurosci., 25, 6734-6744.
11. Caberlotto, L., Fuxe, K., Sedvall, G. & Hurd, Y.L. (1997) Localization of neuropeptideY Y1 mRNA in the human brain: abundant expression in cerebral cortex and striatum. Eur. J. Neurosci., 9, 1212-1225.
12. Caberlotto, L., Fuxe, K., Rimland, J.M., Sedvall, G. & Hurd, Y.L. (1998) Regional distribution of neuropeptideY Y2 receptor messenger RNA in the human post mortem brain. Neuroscience, 86, 167-178.
13. Cannizzaro, C., Tel, B.C., Rose, S., Zeng, B.Y. & Jenner, P. (2003) Increased neuropeptideY mRNA expression in striatum in Parkinson's disease. Brain Res. Mol. Brain Res., 110, 169-176.
14. Christensen, D.Z., Olesen, M.V., Kristiansen, H., Mikkelsen, J.D. & Woldbye, D.P. (2006) Unaltered neuropeptideY (NPY)-stimulated [35S]GTPgammaS binding suggests a net increase in NPY signalling after repeated electroconvulsive seizures in mice. J. Neurosci. Res., 84, 1282-1291.
15. Coelho-Santos, V., Gonçalves, J., Ribeiro, C.F. & Silva, A.P. (2012) Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK/STAT pathway. J. Neuroinflammation, 9, 103.
16. Decressac, M., Pain, S., Chabeauti, P.Y., Frangeul, L., Thiriet, N., Herzog, H., Vergote, J., Chalon, S., Jaber, M. & Gaillard, A. (2011) Neuroprotection by neuropeptideY in cell and animal models of Parkinson's disease. Neurobiol. Aging, 33, 2125-2137.
17. Deng, X., Ladenheim, B., Jayanthi, S. & Cadet, J.L. (2007) Methamphetamine administration causes death of dopaminergic neurons in the mouse olfactory bulb. Biol. Psychiatry, 61, 1235-1243.
18. Duszczyk, M., Ziembowicz, A., Gadamski, R., Wieronska, J.M., Smialowska, M. & Lazarewicz, J.W. (2009) Changes in the NPY immunoreactivity in gerbil hippocampus after hypoxic and ischemic preconditioning. Neuropeptides, 43, 31-39.
19. Ferreira, R., Xapelli, S., Santos, T., Silva, A.P., Cristovao, A., Cortes, L. & Malva, J.O. (2010) NeuropeptideY modulation of interleukin-1{beta} (IL-1{beta})-induced nitric oxide production in microglia. J. Biol. Chem., 285, 41921-41934.
20. Ferreira, R., Santos, T., Cortes, L., Cochaud, S., Agasse, F., Silva, A.P., Xapelli, S. & Malva, J.O. (2011) NeuropeptideY inhibits interleukin-1 beta (IL-1beta)-induced microglia motility. J. Neurochem., 120, 93-105.
21. Gackenheimer, S.L., Schober, D.A. & Gehlert, D.R. (2001) Characterization of neuropeptideY Y1-like and Y2-like receptor subtypes in the mouse brain. Peptides, 22, 335-341.
22. Gavet, O. & Pines, J. (2010a) Activation of cyclin B1-Cdk1 synchronizes events in the nucleus and the cytoplasm at mitosis. J. Cell Biol., 189, 247-259.
23. Gavet, O. & Pines, J. (2010b) Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev. Cell, 18, 533-543.
24. Gehlert, D.R. (2004) Introduction to the reviews on neuropeptideY. Neuropeptides, 38, 135-140.
25. Gonçalves, J., Martins, T., Ferreira, R., Milhazes, N., Borges, F., Ribeiro, C.F., Malva, J.O., Macedo, T.R. & Silva, A.P. (2008) Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain. Ann. N. Y. Acad. Sci., 1139, 103-111.
26. Gonçalves, J., Baptista, S., Martins, T., Milhazes, N., Borges, F., Ribeiro, C.F., Malva, J.O. & Silva, A.P. (2010) Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin. Eur. J. Neurosci., 31, 315-326.
27. Goodman, J.H. & Sloviter, R.S. (1993) Cocaine neurotoxicity and altered neuropeptideY immunoreactivity in the rat hippocampus; a silver degeneration and immunocytochemical study. Brain Res., 616, 263-272.
28. Gotzsche, C.R., Nikitidou, L., Sorensen, A.T., Olesen, M.V., Sorensen, G., Christiansen, S.H., Angehagen, M., Woldbye, D.P. & Kokaia, M. (2011) Combined gene overexpression of neuropeptideY and its receptor Y5 in the hippocampus suppresses seizures. Neurobiol. Dis., 45, 288-296.
29. Gross, A., McDonnell, J.M. & Korsmeyer, S.J. (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev., 13, 1899-1911.
30. Grove, K.L., Campbell, R.E., Ffrench-Mullen, J.M., Cowley, M.A. & Smith, M.S. (2000) Neuropeptide Y Y5 receptor protein in the cortical/limbic system and brainstem of the rat: expression on gamma-aminobutyric acid and corticotropin-releasing hormone neurons. Neuroscience, 100, 731-740.
31. Hadlock, G.C., Baucum, A.J. 2nd, King, J.L., Horner, K.A., Cook, G.A., Gibb, J.W., Wilkins, D.G., Hanson, G.R. & Fleckenstein, A.E. (2009) Mechanisms underlying methamphetamine-induced dopamine transporter complex formation. J. Pharmacol. Exp. Ther., 329, 169-174.
32. Hanisch, U.K. & Kettenmann, H. (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci., 10, 1387-1394.
33. Horner, K.A., Westwood, S.C., Hanson, G.R. & Keefe, K.A. (2006) Multiple high doses of methamphetamine increase the number of preproneuropeptideY mRNA-expressing neurons in the striatum of rat via a dopamine D1 receptor-dependent mechanism. J. Pharmacol. Exp. Ther., 319, 414-421.
34. Huang, C.Y., Liou, Y.F., Chung, S.Y., Lin, W.Y., Jong, G.P., Kuo, C.H., Tsai, F.J., Cheng, Y.C., Cheng, F.C. & Lin, J.Y. (2010) Role of ERK signaling in the neuroprotective efficacy of magnesium sulfate treatment during focal cerebral ischemia in the gerbil cortex. Chin. J. Physiol., 53, 299-309.
35. Karl, T., Duffy, L. & Herzog, H. (2008) Behavioural profile of a new mouse model for NPY deficiency. Eur. J. Neurosci., 28, 173-180.
36. Kish, S.J., Fitzmaurice, P.S., Boileau, I., Schmunk, G.A., Ang, L.C., Furukawa, Y., Chang, L.J., Wickham, D.J., Sherwin, A. & Tong, J. (2009) Brain serotonin transporter in human methamphetamine users. Psychopharmacology, 202, 649-661.
37. Kita, T., Miyazaki, I., Asanuma, M., Takeshima, M. & Wagner, G.C. (2009) Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity. Int. Rev. Neurobiol., 88, 43-64.
38. Kitamura, O., Takeichi, T., Wang, E.L., Tokunaga, I., Ishigami, A. & Kubo, S. (2010) Microglial and astrocytic changes in the striatum of methamphetamine abusers. Leg. Med. (Tokyo), 12, 57-62.
39. Kitazawa, H., Numakawa, T., Adachi, N., Kumamaru, E., Tuerxun, T., Kudo, M. & Kunugi, H. (2010) Cyclophosphamide promotes cell survival via activation of intracellular signaling in cultured cortical neurons. Neurosci. Lett., 470, 139-144.
40. Kluck, R.M., Bossy-Wetzel, E., Green, D.R. & Newmeyer, D.D. (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science, 275, 1132-1136.
41. LaVoie, M.J., Card, J.P. & Hastings, T.G. (2004) Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity. Exp. Neurol., 187, 47-57.
42. Martins, T., Baptista, S., Goncalves, J., Leal, E., Milhazes, N., Borges, F., Ribeiro, C.F., Quintela, O., Lendoiro, E., Lopez-Rivadulla, M., Ambrosio, A.F. & Silva, A.P. (2011) Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9. Brain Res., 1411, 28-40.
43. McQuiston, A.R., Petrozzino, J.J., Connor, J.A. & Colmers, W.F. (1996) NeuropeptideY1 receptors inhibit N-type calcium currents and reduce transient calcium increases in rat dentate granule cells. J. Neurosci., 16, 422-429.
44. Michel, M.C., Beck-Sickinger, A., Cox, H., Doods, H.N., Herzog, H., Larhammar, D., Quirion, R., Schwartz, T. & Westfall, T. (1998) XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptideY, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev., 50, 143-150.
45. Mitic, K., Stanojevic, S., Kustrimovic, N., Vujic, V. & Dimitrijevic, M. (2011) NeuropeptideY modulates functions of inflammatory cells in the rat: distinct role for Y1, Y2 and Y5 receptors. Peptides, 32, 1626-1633.
46. Mullins, D.E., Zhang, X. & Hawes, B.E. (2002) Activation of extracellular signal regulated protein kinase by neuropeptideY and pancreatic polypeptide in CHO cells expressing the NPY Y(1), Y(2), Y(4) and Y(5) receptor subtypes. Regul. Pept., 105, 65-73.
47. Nakagawa, T., Suzuki, Y., Nagayasu, K., Kitaichi, M., Shirakawa, H. & Kaneko, S. (2011) Repeated exposure to methamphetamine, cocaine or morphine induces augmentation of dopamine release in rat mesocorticolimbic slice co-cultures. PLoS One, 6, e24865.
48. Nakama, H., Chang, L., Cloak, C., Jiang, C., Alicata, D. & Haning, W. (2008) Association between psychiatric symptoms and craving in methamphetamine users. Am. J. Addict., 17, 441-446.
49. Nave, H., Bedoui, S., Moenter, F., Steffens, J., Felies, M., Gebhardt, T., Straub, R.H., Pabst, R., Dimitrijevic, M., Stanojevic, S. & von Horsten, S. (2004) Reduced tissue immigration of monocytes by neuropeptideY during endotoxemia is associated with Y2 receptor activation. J. Neuroimmunol., 155, 1-12.
50. Nichol, K.A., Morey, A., Couzens, M.H., Shine, J., Herzog, H. & Cunningham, A.M. (1999) Conservation of expression of neuropeptideY5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control. J. Neurosci., 19, 10295-10304.
51. Nopparat, C., Porter, J.E., Ebadi, M. & Govitrapong, P. (2010) The mechanism for the neuroprotective effect of melatonin against methamphetamine-induced autophagy. J. Pineal Res., 49, 382-389.
52. Olesen, M.V., Christiansen, S.H., Gotzsche, C.R., Nikitidou, L., Kokaia, M. & Woldbye, D.P. (2012) NeuropeptideY Y1 receptor hippocampal overexpression via viral vectors is associated with modest anxiolytic-like and proconvulsant effects in mice. J. Neurosci. Res., 90, 498-507.
53. Olling, J.D., Ulrichsen, J., Haugbol, S., Glenthoj, B., Hemmingsen, R. & Woldbye, D.P. (2007) Decreased gene expression of neuropeptideY and its receptors in hippocampal regions during ethanol withdrawal in rats. Neurosci. Lett., 424, 160-164.
54. Pocock, J.M. & Kettenmann, H. (2007) Neurotransmitter receptors on microglia. Trends Neurosci., 30, 527-535.
55. Potapova, T.A., Sivakumar, S., Flynn, J.N., Li, R. & Gorbsky, G.J. (2011) Mitotic progression becomes irreversible in prometaphase and collapses when Wee1 and Cdc25 are inhibited. Mol. Biol. Cell, 22, 1191-1206.
56. Qian, J., Colmers, W.F. & Saggau, P. (1997) Inhibition of synaptic transmission by neuropeptideY in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry. J. Neurosci., 17, 8169-8177.
57. Sekine, Y., Ouchi, Y., Sugihara, G., Takei, N., Yoshikawa, E., Nakamura, K., Iwata, Y., Tsuchiya, K.J., Suda, S., Suzuki, K., Kawai, M., Takebayashi, K., Yamamoto, S., Matsuzaki, H., Ueki, T., Mori, N., Gold, M.S. & Cadet, J.L. (2008) Methamphetamine causes microglial activation in the brains of human abusers. J. Neurosci., 28, 5756-5761.
58. Silva, A.P., Carvalho, A.P., Carvalho, C.M. & Malva, J.O. (2001) Modulation of intracellular calcium changes and glutamate release by neuropeptideY1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus. J. Neurochem., 79, 286-296.
59. Silva, A.P., Pinheiro, P.S., Carvalho, A.P., Carvalho, C.M., Jakobsen, B., Zimmer, J. & Malva, J.O. (2003a) Activation of neuropeptideY receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures. FASEB J., 17, 1118-1120.
60. Silva, A.P., Carvalho, A.P., Carvalho, C.M. & Malva, J.O. (2003b) Functional interaction between neuropeptideY receptors and modulation of calcium channels in the rat hippocampus. Neuropharmacology, 44, 282-292.
61. Silva, A.P., Xapelli, S., Grouzmann, E. & Cavadas, C. (2005a) The putative neuroprotective role of neuropeptideY in the central nervous system. Curr. Drug Targets CNS Neurol. Disord., 4, 331-347.
62. Silva, A.P., Xapelli, S., Pinheiro, P.S., Ferreira, R., Lourenco, J., Cristovao, A., Grouzmann, E., Cavadas, C., Oliveira, C.R. & Malva, J.O. (2005b) Up-regulation of neuropeptideY levels and modulation of glutamate release through neuropeptideY receptors in the hippocampus of kainate-induced epileptic rats. J. Neurochem., 93, 163-170.
63. Silva, A.P., Lourenco, J., Xapelli, S., Ferreira, R., Kristiansen, H., Woldbye, D.P., Oliveira, C.R. & Malva, J.O. (2007) Protein kinase C activity blocks neuropeptideY-mediated inhibition of glutamate release and contributes to excitability of the hippocampus in status epilepticus. FASEB J., 21, 671-681.
64. Silva, A.P., Martins, T., Baptista, S., Goncalves, J., Agasse, F. & Malva, J.O. (2010) Brain injury associated with widely abused amphetamines: neuroinflammation, neurogenesis and blood-brain barrier. Curr. Drug Abuse Rev., 3, 239-254.
65. Smialowska, M., Domin, H., Zieba, B., Kozniewska, E., Michalik, R., Piotrowski, P. & Kajta, M. (2009) Neuroprotective effects of neuropeptideY-Y2 and Y5 receptor agonists in vitro and in vivo. Neuropeptides, 43, 235-249.
66. Smith, K.J., Butler, T.R. & Prendergast, M.A. (2010) Inhibition of sigma-1 receptor reduces N-methyl-D-aspartate induced neuronal injury in methamphetamine-exposed and -naive hippocampi. Neurosci. Lett., 481, 144-148.
67. Sorensen, A.T., Kanter-Schlifke, I., Carli, M., Balducci, C., Noe, F., During, M.J., Vezzani, A. & Kokaia, M. (2008) NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning. Hippocampus, 18, 564-574.
68. Sperk, G., Hamilton, T. & Colmers, W.F. (2007) Neuropeptide Y in the dentate gyrus. Prog. Brain Res., 163, 285-297.
69. Stoppini, L., Buchs, P.A. & Muller, D. (1991) A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods, 37, 173-182.
70. St-Pierre, J.A., Nouel, D., Dumont, Y., Beaudet, A. & Quirion, R. (2000) Sub-population of cultured hippocampal astrocytes expresses neuropeptide Y Y(1) receptors. Glia, 30, 82-91.
71. Thiele, T.E., Sparta, D.R., Hayes, D.M. & Fee, J.R. (2004) A role for neuropeptideY in neurobiological responses to ethanol and drugs of abuse. Neuropeptides, 38, 235-243.
72. Thiriet, N., Deng, X., Solinas, M., Ladenheim, B., Curtis, W., Goldberg, S.R., Palmiter, R.D. & Cadet, J.L. (2005) NeuropeptideY protects against methamphetamine-induced neuronal apoptosis in the mouse striatum. J. Neurosci., 25, 5273-5279.
73. Thompson, P.M., Hayashi, K.M., Simon, S.L., Geaga, J.A., Hong, M.S., Sui, Y., Lee, J.Y., Toga, A.W., Ling, W. & London, E.D. (2004) Structural abnormalities in the brains of human subjects who use methamphetamine. J. Neurosci., 24, 6028-6036.
74. Woldbye, D.P., Nanobashvili, A., Sorensen, A.T., Husum, H., Bolwig, T.G., Sorensen, G., Ernfors, P. & Kokaia, M. (2005) Differential suppression of seizures via Y2 and Y5 neuropeptideY receptors. Neurobiol. Dis., 20, 760-772.
75. Woldbye, D.P., Angehagen, M., Gotzsche, C.R., Elbrond-Bek, H., Sorensen, A.T., Christiansen, S.H., Olesen, M.V., Nikitidou, L., Hansen, T.V., Kanter-Schlifke, I. & Kokaia, M. (2010) Adeno-associated viral vector-induced overexpression of neuropeptideY Y2 receptors in the hippocampus suppresses seizures. Brain, 133, 2778-2788.
76. Xapelli, S., Agasse, F., Ferreira, R., Silva, A.P. & Malva, J.O. (2006) NeuropeptideY as an endogenous antiepileptic, neuroprotective and pro-neurogenic peptide. Recent Pat. CNS Drug Discov., 1, 315-324.
77. Xapelli, S., Silva, A.P., Ferreira, R. & Malva, J.O. (2007) NeuropeptideY can rescue neurons from cell death following the application of an excitotoxic insult with kainate in rat organotypic hippocampal slice cultures. Peptides, 28, 288-294.
78. Xapelli, S., Bernardino, L., Ferreira, R., Grade, S., Silva, A.P., Salgado, J.R., Cavadas, C., Grouzmann, E., Poulsen, F.R., Jakobsen, B., Oliveira, C.R., Zimmer, J. & Malva, J.O. (2008) Interaction between neuropeptideY (NPY) and brain-derived neurotrophic factor in NPY-mediated neuroprotection against excitotoxicity: a role for microglia. Eur. J. Neurosci., 27, 2089-2102.
79. Yamamoto, B.K., Moszczynska, A. & Gudelsky, G.A. (2010) Amphetamine toxicities: classical and emerging mechanisms. Ann. N. Y. Acad. Sci., 1187, 101-121.